March 22, 2018
This year’s flagship event will gather top EU, US, Asia and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilar & biologics medicines sector.
The BioTech Pharma Summit: Gut-Brain Axis 2018 will be dedicated to help large pharma, biotech, academics and clinicians exploring and understand the GBA in demonstrating disease causation.
Global Vaccines & Immunization 2018 will create a forum to improve knowledge translation to identify, discuss and troubleshoot the current Vaccine and Immunology related issues across a range of disciplines and tracks
The BioTech Pharma Summit: AI Pharma 2018 will showcase the real world application and impact of AI, machine learning, deep learning and cognitive approaches to unlock insight and value along the drug discovery and development pipeline to deliver better medicines with better outcomes.
The BioTech Pharma Summit: Pre-Filled Syringes 2018 will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
The BioTech Pharma Summit: Drug Delivery & Formulation 2018 provides drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
Seoul, South Korea
September 24, 2018
With the global Orphan Drug market expected to grow to $127 billion by 2018-2019, and another Rare Disease Day just having passed, there is a constantly growing awareness and interest for this industry, enabling more research to make a difference in patients’ lives.
October 15, 2018
The BioTech Pharma Summit: Liquid Biopsy 2018 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.